Genetic associations among internalizing and externalizing traits with polysubstance use among young adults

Though most genetic studies of substance use focus on specific substances in isolation or generalized vulnerability across multiple substances, few studies to date focus on the concurrent use of two or more substances within a specified time frame (i.e., polysubstance use; PSU). We evaluated whether distinct genetic factors underlying internalizing and externalizing traits were associated with past 30-day PSU above variance shared across general psychopathology and substance use (SU). Using Genomic Structural Equation Modeling, we constructed theory-driven, multivariate genetic factors of 16 internalizing, externalizing, and SU traits using genome-wide association studies (GWAS) summary statistics. Next, we fit a model with a higher order SU-related psychopathology factor as well as genetic variance specific to externalizing and internalizing (i.e., residual genetic variance not explained by SU or general psychopathology). GWAS-by-subtraction was used to obtain single nucleotide polymorphism effects on each of these factors. Polygenic scores (PGS) were then created in an independent target sample with data on PSU, the National Longitudinal Study of Adolescent to Adult Health. To evaluate the effect of genetic variance due to internalizing and externalizing traits independent of variance related to SU, we regressed PSU on the PGSs, controlling for sex, age, and genetic principal components. PGSs for SU-related psychopathology and non-SU externalizing traits were associated with higher PSU factor scores, while the non-SU internalizing PGS was not significantly associated with PSU. In total, the three PGSs accounted for an additional 4% of the variance in PSU above and beyond a null model with only age, sex, and genetic principal components as predictors. These findings suggest that there may be unique genetic variance in externalizing traits contributing to liability for PSU that is independent of the genetic variance shared with SU.

[1]  Blair E. Wisco,et al.  Understanding internalizing and externalizing symptoms in trauma exposed community members. , 2022, Psychological trauma : theory, research, practice and policy.

[2]  E. Prom-Wormley,et al.  A network approach to substance use, internalizing, and externalizing comorbidity in U.S. adults. , 2022, Addictive behaviors.

[3]  M. Fleury,et al.  Frequencies of emergency department use and hospitalization comparing patients with different types of substance or polysubstance-related disorders , 2021, Substance Abuse Treatment, Prevention, and Policy.

[4]  A. Agrawal,et al.  The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates , 2021, Neuropsychopharmacology.

[5]  Dajiang J. Liu,et al.  Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction , 2021, Nature Neuroscience.

[6]  J. Gelernter,et al.  Genetics of substance use disorders in the era of big data , 2021, Nature Reviews Genetics.

[7]  D. Smit,et al.  The CADM2 Gene and Behavior: A Phenome-Wide Scan in UK-Biobank , 2021, Behavior Genetics.

[8]  L. Brick,et al.  The intermediary role of adolescent temperamental and behavioral traits on the prospective associations between polygenic risk and cannabis use among young adults of European Ancestry. , 2021, Addiction.

[9]  D. Belsky,et al.  Investigating the genetic architecture of noncognitive skills using GWAS-by-subtraction , 2021, Nature Genetics.

[10]  N. Davis,et al.  Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants — 24 States and the District of Columbia, January–June 2019 , 2020, MMWR. Morbidity and mortality weekly report.

[11]  Christopher R. Erbes,et al.  International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci , 2019, Nature Communications.

[12]  John J. Foxe,et al.  Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders , 2019, Neuroscience & Biobehavioral Reviews.

[13]  H. Coon,et al.  Genome-wide association study of suicide death and polygenic prediction of clinical antecedents , 2019, bioRxiv.

[14]  I. Deary,et al.  Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts. , 2019, The American journal of psychiatry.

[15]  Jonathan P. Beauchamp,et al.  Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences , 2019, Nature Genetics.

[16]  G. Willemsen,et al.  Multivariate genome-wide analyses of the well-being spectrum , 2019, Nature Genetics.

[17]  Dajiang J. Liu,et al.  Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use , 2018, Nature Genetics.

[18]  Alicia R. Martin,et al.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder , 2018, Nature Genetics.

[19]  T. Ge,et al.  Polygenic prediction via Bayesian regression and continuous shrinkage priors , 2018, bioRxiv.

[20]  Zachary F. Gerring,et al.  GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability , 2018, Nature Neuroscience.

[21]  J. Perry,et al.  Elucidating the genetic basis of social interaction and isolation , 2018, Nature Communications.

[22]  R. Marioni,et al.  Edinburgh Research Explorer Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways , 2022 .

[23]  L. Hawk,et al.  Internalizing and Externalizing Problem Behavior: a Test of a Latent Variable Interaction Predicting a Two-Part Growth Model of Adolescent Substance Use , 2018, Journal of abnormal child psychology.

[24]  Kevin M. Beaver,et al.  Genome-Wide Association Studies of a Broad Spectrum of Antisocial Behavior , 2017, JAMA psychiatry.

[25]  D. Posthuma,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[26]  Brady T. West,et al.  Multiple DSM‐5 substance use disorders: A national study of US adults , 2017, Human psychopharmacology.

[27]  D. Washington,et al.  Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. , 2017, Drug and alcohol dependence.

[28]  D. Satre,et al.  Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. , 2017, Journal of addiction medicine.

[29]  W. Iacono,et al.  An Integrative Common Liabilities Model for the Comorbidity of Substance Use Disorders with Externalizing and Internalizing Disorders , 2016 .

[30]  N. Wray,et al.  Meta-analysis of genome-wide association studies of anxiety disorders , 2016, Molecular Psychiatry.

[31]  Jonathan P. Beauchamp,et al.  Genetic variants associated with subjective well-being, depressive symptoms and neuroticism identified through genome-wide analyses , 2016, Nature Genetics.

[32]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[33]  A. Kelly,et al.  The relationship between psychological distress and adolescent polydrug use. , 2015, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[34]  L. C. Bidwell,et al.  Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. , 2015, Addiction.

[35]  Michael J. Kofler,et al.  The emergence of co-occurring adolescent polysubstance use and depressive symptoms: A latent growth modeling approach , 2015, Development and Psychopathology.

[36]  M. Gullo,et al.  Polysubstance use: diagnostic challenges, patterns of use and health , 2014, Current opinion in psychiatry.

[37]  Hsiao-ye Yi,et al.  Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample. , 2014, Drug and alcohol dependence.

[38]  M. Janosz,et al.  Latent Classes of Substance Use in Adolescent Cannabis Users: Predictors and Subsequent Substance-Related Harm , 2014, Front. Psychiatry.

[39]  J. Elhai,et al.  Polydrug use typologies and childhood maltreatment in a nationally representative survey of Danish young adults. , 2014, Journal of studies on alcohol and drugs.

[40]  L. Hawk,et al.  Prospective Associations of Internalizing and Externalizing Problems and Their Co-Occurrence with Early Adolescent Substance Use , 2013, Journal of abnormal child psychology.

[41]  J. Hewitt,et al.  Genetic etiology of the common liability to drug dependence: evidence of common and specific mechanisms for DSM-IV dependence symptoms. , 2012, Drug and alcohol dependence.

[42]  Michael Farrell,et al.  Patterns of polydrug use in Great Britain: findings from a national household population survey. , 2011, Drug and alcohol dependence.

[43]  T. Gilreath,et al.  A multiprocess latent class analysis of the co-occurrence of substance use and sexual risk behavior among adolescents. , 2009, Journal of studies on alcohol and drugs.

[44]  Kim Chantala,et al.  Guidelines for Analyzing Add Health Data , 2006 .